The post-prandial pattern of gut hormones is related to magnitude of weight-loss following gastric bypass surgery: A case-control study

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 74, Issue 3, 2014, Pages 213-218

  Gerner, Tom ^a   Johansen, Odd Erik ^a   Olufsen, Mona ^a   Torjesen, Peter A ^b   Tveit, Arnljot ^a  

^a VESTRE VIKEN HOSPITAL TRUST   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Digestion; Ghrelin; GLP 1; Obesity; PYY; Surgery

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY;

ADULT; ANASTOMOSIS DEHISCENCE; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; KIDNEY FUNCTION; LIMIT OF DETECTION; MALE; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; REDUCTION; ROUX Y ANASTOMOSIS; WEIGHT REDUCTION; AREA UNDER THE CURVE; BLOOD; METABOLISM; MIDDLE AGED; OBESITY, MORBID; STOMACH; STOMACH BYPASS; SURGERY;

ADULT; ANASTOMOSIS, ROUX-EN-Y; AREA UNDER CURVE; FEMALE; GASTRIC BYPASS; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PEPTIDE YY; POSTPRANDIAL PERIOD; STOMACH; WEIGHT LOSS;

EID: 84898491239     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.877594     Document Type: Article

References (22)

1. Latner JG, Stunkard A J, Wilso GT. Stigmatized students: Age, sex, and ethnicity effects in the stigmatization of obesity. Obesity Res 2005;13:1226-31
2. Guallar-Castillon P, Sagardui-Villamor J, Banegas J R, Graciani A, Forn é s NS, L ó pez Garcia E, Rodr í guez-Artalejo F. Waist circumference as a predictor of disability among older adults. Obesity 2007;15:233-44
3. Peeters A, Barendregt J J, Willekens F, Mackenbach JP, AI Mamun A, Bonneux L, NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: A life table analysis. Ann Int Med 2003;138:24-32
4. Haslam DW, James WP. Obesity. Lancet 2005; 3 66: 1197-209
5. Flegal KM Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012 ;307: 491-7
6. Foster-Schubert K E, Cummings D E. Emerging therapeutic strategies for obesity. Endocrine Rev 2006;27:779-93
7. Sj øs tr øm L, Peltonen M, Jacobson P, S j ös tr öm C D, Karason K, Wedel H, Ahlin S, Anveden Å, Bengtsson C, Bergmark G, Bouchard C, Carlsson B, Dahlgren S, Karlsson J, Lindroos AK, L ö nroth H, Narbro K, N ä slund I, Olbers T, Svensson PA, Carlsson LM. Bariatric surgery and long-Term cardiovascular events. JAMA 2012;307:56-65
8. Sj øs tr øm L. Bariatric surgery and reduction in morbidity and mortality: Experiences from the SOS study. Int J Obes (Lond) 2008;32(Suppl. 7):593-7
9. Buchwald H. Bariatric surgery for morbid obesity: Health implications for patients, health professionals, and third-party-payers. JAm Coll Surg 2005;200:593-604
10. Aarts EO, van Wageningen B, Janssen IM, Berends FJ. Prevalence of anemia and related defi ciencies in the fi rst year following laparoscopic gastric bypass for morbid obesity. J Obes 2012;2012:Article ID 193705,1-7
11. Ranganath LR. The entero-insular axis: Implications for human metabolism. Clin Chem Lab Med 2008;46:43-56
12. le Roux CW, Welbourn R, Werling M Werling M, Osborne A, Kokkinos A, Laurenius A, L ö nroth H, F ä ndriks L, Ghatei MA, Bloom SR, Olbers T. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007;246:780-5
13. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. JClin Invest 2007;117:13-23
14. Beckman L M, Beckman TR, Sibley S D, Thomas W, Ikramuddin S, Kellogg TA, Ghatei MA, Bloom SR, le Roux CW, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. J Parenter Enteral Nutr 2011;35:169-80
15. Cummings D E, Weigle D S, Frayo R S, Breen P A, M a M K, Dellinger EP, Purnell JQ. Plasma ghrelin levels after diet induced weight loss or gastric bypass surgery. NEngl J Med 2002;346:1623-30
16. Lin E, Gletsu N, Fugate K, McClusky D, G u LH, Zhu JL, Ramshaw BJ, Papanicolaou DA, Ziegler TR, Smith CD. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg 2004;139:780-4
17. Rodieux F, Giusti V, D 'A lessio D A, Suter M, Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity 2008;16;298-305
18. Korner J, Inabnet W, Febres G C onwell I M, McMahon DJ, Salas R, Taveras C, Schrope B, Bessler M. Prospective studies of gut hormone and metabolic changes after adjustable gastric banding and Roux-en Y gastric bypass. Int J Obes 2009;33:786-95
19. Holdstock C, Engstr öm B E, Ohrwall M, Lind L, Sundbom M, Karlsson FA. Ghrelin and adipose tissue regulatory peptides: Effect of gastric bypass surgery in obese humans. JClin Endocrinol Metab 2003;88:3177-83
20. Garcia-Fuentes E, Garrido-Sanchez L, Garcia-Almeida JM, Garcia-Arnes J, Gallego-Perales JL, Rivas-Marin J, Morcillo S, Cardona I, Soriguer F. Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of Scopinaro on serum PYY and ghrelin levels. Obes Surg 2008;18:1424-9
21. le Roux C W, Aylwin S J, Batterham R L, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR. Gut hormone profi les following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;243:108-14
22. Peterli R, Steinert R E, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, Kern B, von Fluee M, Beglinger C. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: A randomized, prospective trial. Obes Surg 2012;22:740-8